Items Tagged ‘Thyroid Cancer’

June 6th, 2017

Targeted Therapies Show Initial Effectiveness in Subset of Papillary Thyroid Cancer

By

Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer. Up to 44 percent of papillary thyroid cancer patients have a B-raf mutation that can be specifically targeted by existing cancer drugs. The […]

View full entry

Tags: B-raf mutations, mekinist, News, papillary thyroid cancer, precision medicine, tafinlar, targeted therapy, Thyroid Cancer


March 3rd, 2017

Thyroid Cancer Survivors May Have Increased Risk of Osteoporosis and Heart Conditions

By

The results of a recent new study find that younger survivors of thyroid cancer are at increased risk for osteoporosis, high blood pressure and heart disease.  Thyroid cancer is the fifth most common cancer in women. The thyroid gland is a butterfly-shaped organ that is below the Adam’s apple in the front part of the […]

View full entry

Tags: News, osteoporosis, Thyroid Cancer


April 6th, 2016

Complications Decrease with Surgeon Experience in Thyroidectomy

By

Among patients undergoing the surgical removal of their thyroid, complications associated with the procedure are drastically reduced if surgeons perform a larger number of the surgeries per year. These results were recently published in the Annals of Surgery. The thyroid is a small, butterfly-shaped gland that is located at the base of the neck. It […]

View full entry

Tags: complications, failure, General Thyroid Cancer, success, surgeon, surgery, Thyroid Cancer, thyroidectomy


May 28th, 2015

Lenvima®

By

Class: Biological Therapy Generic Name: Lenvatinib Trade Name: Lenvima® For which conditions is this drug approved? Lenvima is approved to treat people with a type of thyroid cancer called differentiated thyroid cancer (DTC) when the disease can no longer be treated with radioactive iodine and is progressing. It is also indicated for patients with advanced renal […]

View full entry

Tags: Biological Therapy, differentiated thyroid cancer, Drug Dictionary, L, lenvatinib, Lenvima, Thyroid Cancer


May 28th, 2015

Lenvatinib

By

Class: Biological Therapy Generic Name: Lenvatinib Trade Name: Lenvima® For which conditions is this drug approved? Lenvima is approved to treat people with a type of thyroid cancer called differentiated thyroid cancer (DTC) when the disease can no longer be treated with radioactive iodine and is progressing. It is also indicated for patients with advanced renal […]

View full entry

Tags: Biological Therapy, differentiated thyroid cancer, Drug Dictionary, L, lenvatinib, Lenvima, Thyroid Cancer


May 21st, 2015

More Risk than Benefit with TSH Suppression in Thyroid Cancer without High Risk of Recurrence

By

For patients undergoing treatment for thyroid cancer who aren’t at high risk of recurrence, therapy to suppress thyrotropin (TSH) may be ineffective as well as risky. These findings were published in the journal Thyroid. Differentiated thyroid cancer is the most common type of thyroid cancer and can often be cured with surgery to remove the […]

View full entry

Tags: News, Thyroid Cancer, TSH suppression


May 19th, 2015

Target Therapy Sutent® Promising in Advanced Thyroid Cancer

By

The targeted therapy Sutent® (sunitinib) appears effective in the treatment of patients with advanced differentiated thyroid cancers. The Endocrine Society announced these Phase II trial findings in a press release. Study results were also presented at the Endocrine Society’s 97th annual meeting in San Diego, March 5–8, 2015. Differentiated thyroid cancer is the most common […]

View full entry

Tags: News, sunitinib, Sutent, targeted therapy, Thyroid Cancer


April 16th, 2015

Important Clues in the Development of Aggressive Thyroid Cancer

By

New insight into how anaplastic thyroid cancer (ATC) grows and spreads may provide important direction in the development of treatment. These findings were published in the Journal of Clinical Endocrinology and Metabolism. The thyroid is a gland in the throat that produces hormones mostly related to metabolic processes in the body. There are different types of […]

View full entry

Tags: anaplastic thyroid cancer, ATC, News, S100A8, S100A9, Thyroid Cancer


December 9th, 2013

Nexavar Approved for Metastatic Differentiated Thyroid Cancer

By

The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid cancer and can often be cured with surgery and radioactive iodine (RAI) treatment. In some cases, however, the cancer is resistant to RAI. RAI-resistant thyroid cancers […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


November 15th, 2013

Mutations Linked to Drug Response in Medullary Thyroid Cancer

By

Metastatic medullary thyroid cancers with certain genetic mutations respond better to treatment with Cometriq™ (cabozantinib) than tumors without those mutations, according to the results of a study presented at the 83rd Annual Meeting of the American Thyroid Association, October 16- 20, 2013, in San Juan, Puerto Rico. The thyroid is a gland in the throat […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


November 4th, 2013

TSH Suppression after Thyroidectomy May Not Be Beneficial

By

Suppression of thyroid-stimulating hormone (TSH) after thyroidectomy for low-risk cancer does not appear to reduce the risk of cancer recurrence and may even increase the risk of osteoporosis in women, according to the results of a study presented at the 83rd Annual Meeting of the American Thyroid Association, October 16- 20, 2013, in San Juan, […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


September 16th, 2013

End-of-Life Care Remains Aggressive, Despite Patient Wishes

By

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive intensive treatment until the last month of life and hospice care is often delayed until the final three […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, HIV Related Cancers


September 13th, 2013

Thyroid Ultrasound May Cut Biopsy Rate

By

Thyroid ultrasound may help identify certain characteristics of thyroid nodules that can predict the likelihood of cancer—and subsequently help determine whether biopsy is necessary, according to the results of a study published in the Journal of the American Medical Association. The thyroid gland is located in the front of the neck and is attached to […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer


June 17th, 2013

Nexavar Shows Promise Against Aggressive Thyroid Cancers

By

The targeted drug Nexavar® (sorafenib) delays the growth of treatment-resistant, differentiated thyroid cancers. These results—from a Phase III clinical trial—were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO). Differentiated thyroid cancer is the most common type of thyroid cancer and can often be cured with surgery and radioactive iodine […]

View full entry

Tags: Thyroid Cancer


June 5th, 2013

BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer

By

The presence of the BRAF V600E mutation is significantly associated with increased cancer-related death among patients with papillary thyroid cancer, according to the results of a study published in the Journal of the American Medical Association. The thyroid gland is located in the front of the neck and is attached to the lower part of the voice box […]

View full entry

Tags: General Thyroid Cancer, News, Thyroid Cancer